<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Celgene Corporation Announces Initial Clinical Data from Ongoing Phase 1/2 Evolve Trial with Anti-BCMA CAR T Therapy JCARH125 in Relapsed/Refractory Multiple Myeloma at ASH 2018	</title>
	<atom:link href="https://www.novumpr.nl/2018/12/04/celgene-corporation-announces-initial-clinical-data-from-ongoing-phase-12-evolve-trial-with-anti-bcma-car-t-therapy-jcarh125-in-relapsedrefractory-multiple-myeloma-at-ash-2018/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.novumpr.nl/2018/12/04/celgene-corporation-announces-initial-clinical-data-from-ongoing-phase-12-evolve-trial-with-anti-bcma-car-t-therapy-jcarh125-in-relapsedrefractory-multiple-myeloma-at-ash-2018/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=celgene-corporation-announces-initial-clinical-data-from-ongoing-phase-12-evolve-trial-with-anti-bcma-car-t-therapy-jcarh125-in-relapsedrefractory-multiple-myeloma-at-ash-2018</link>
	<description>NovumPR press releases</description>
	<lastBuildDate>Tue, 04 Dec 2018 09:24:24 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.3</generator>
</channel>
</rss>
